tiprankstipranks
Pfizer (PFE)
NYSE:PFE
US Market
PFE
Pfizer
RESEARCH TOOLSreports

Pfizer (PFE) Drug Pipeline

36,171 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Oral [14C]Pf-07328948, Oral Unlabeled Pf-07328948, Iv [14C]Pf-07328948
Healthy
Phase I
Not Yet Recruiting
A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male Adults
Mar 27, 2026
―
Tafamidis
Attr-Pn
Phase I
Not Yet Recruiting
A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions
Mar 10, 2026
Etrasimod
Colitis, Ulcerative
Phase II
Not Yet Recruiting
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Mar 10, 2026
Pf-07328948
Healthy Participant
Phase I
Not Yet Recruiting
A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults
Mar 03, 2026
Vaccine Candidate #1, Vaccine Candidate #2, Vaccine Candidate #3, Vaccine Candidate #4, Vaccine Candidate #5, Vaccine Candidate #6, Tiv1 Or Tiv2
Healthy Adults
Phase II
Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Feb 19, 2026
Midazolam, Pf-07994525
Advanced Cancer, Advanced Malignancies
Phase I
Not Yet Recruiting
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
Feb 16, 2026
Pf-08653944, Met097
Type 2 Diabetes, Overweight, Obesity, Diabetes, Type 2, Overweight And/Or Obesity
Phase III
Not Yet Recruiting
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
Feb 03, 2026
Pf-08653944, Met097
Obesity, Overweight, Healthy
Phase I
Recruiting
A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity.
Feb 03, 2026
Pf-07275315 Dose 1, Pf-07275315-Dose 2, Pf-07275315-Dose 3
Moderate To Severe Chronic Obstructive Pulmonary Disease
Phase III
Not Yet Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Jan 22, 2026
Itraconazole, Pf-07248144
Healthy Adult Participants
Phase I
Active Not Recruiting
A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine)
Jan 05, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Pfizer (PFE) have in its pipeline
      PFE is currently developing the following drugs: Oral [14C]Pf-07328948, Oral Unlabeled Pf-07328948, Iv [14C]Pf-07328948, Tafamidis, Etrasimod. These drug candidates are in various stages of clinical development as the company works toward FDA approval.